New Orleans biotech advances non-opioid ache drug

Hearken to this text A New Orleans-based biotech firm has developed a breakthrough non-opioid ache medicine, which is backed by funding from Ochsner Ventures, the funding arm of Ochsner Well being, and from Gulf South Angels (GSA), the area’s main angel investor…